Bondronat achieves better outcomes in metastatic bone disease Ingo Diel CGG-Klinik GmbH Mannheim, Germany.
Bondronat achieves better outcomes in metastatic bone disease
Advances in the Management of Skeletal Related Events/Bone Metastases in Prostate Cancer Robert Dreicer, M.D., M.S., FACP, FASCO Chair Dept of Solid Tumor.
